Ewing Weight Loss Clinic

Ewing Weight Loss Clinic of Reno, Nevada, offers supplementary Hormone Replacement Therapy (HRT) for those in need. As of April 2025, here is a comprehensive list of drugs used to address hormone therapy:

Existing HRT Options

Hormone Replacement Therapy for Women:

Estrogen, Progesterone, and Combination Therapy

• Premarin (conjugated estrogens) — very commonly prescribed for menopausal symptoms.
• Estrace (estradiol) — oral or vaginal form of bioidentical estrogen.
• Vivelle-Dot / Climara (estradiol patches) — transdermal estrogen therapy.
• Divigel, Estrogel, Elestrin — topical estrogen gels.
• Provera (medroxyprogesterone acetate) — synthetic progestin often combined with estrogen.
• Prometrium (micronized progesterone) — bioidentical progesterone (oral capsule form).
• Combipatch — a patch delivering both estrogen and progestin.
• Bijuva — an oral capsule combining bioidentical estradiol and progesterone.

Hormone Replacement Therapy for Men:

Testosterone Replacement Therapy

• AndroGel (testosterone gel) — widely used for low testosterone.
• Testim, Fortesta — alternative testosterone gels.
• Aveed — long-acting injectable testosterone undecanoate.
• Depo-Testosterone, Delatestryl — older injectable forms of testosterone cypionate or enanthate.
• Natesto — a nasal testosterone gel.
• Axiron — testosterone topical solution (less common now).
• Testosterone pellets (e.g., Testopel) — implanted under the skin for slow release.

Available at Ewing Weight Loss Clinic, Hormone Replacement Therapy is effective for both weight loss and the maintenance of balanced, optimal personal health. Contact Us for details, or call: 775-322-3011.

Emerging HRT Options

Hormone Replacement Therapy for Women:

Prasterone (Intrarosa) expansion — vaginal inserts with DHEA to address painful intercourse (dyspareunia). Prasterone is under more studies for broader systemic HRT benefits.

Bijuva — although already FDA-approved, it’s expanding its market footprint heavily in 2025 as doctors look for bioidentical, single-capsule solutions.

Tsebi — an oral estrogen and bazedoxifene (a SERM) combo in final-stage trials aiming to reduce breast cancer risk while treating menopause symptoms.

Fezolinetant (Veozah) — approved in 2023 for hot flashes; not a traditional hormone but a neurokinin-3 receptor antagonist; it’s getting massive traction among women wanting non-hormonal options for menopause.

New microdosed estradiol vaginal tablets and rings (e.g., low-dose Estring alternatives) coming to market for localized symptom control without systemic effects.

Hormone Replacement Therapy for Men:

Kyzatrex — a newer oral testosterone therapy approved recently (2022), gaining more adoption into 2024 and 2025 as a convenient alternative to injections/gels.

TLANDO — another oral testosterone (testosterone undecanoate capsule) approved, also building momentum.

Longer-acting testosterone injections (bi-annual or even annual injections) are being refined to minimize frequent doctor visits (building off Aveed’s model).

Gender-Affirming HRT (for transgender patients):

Injectable estradiol valerate and micronized progesterone custom compounding continues to expand.

Research into longer-acting estrogens and testosterone for trans patients is becoming a bigger pharmaceutical focus (few drugs named yet, but multiple studies underway).